Limaca Medical is a leading brand in the field of precision medicine, specializing in endoscopic ultrasound-guided biopsy. Their innovative product, Precision™, is designed to deliver high-grade biopsy samples for advanced diagnosis, revolutionizing the biopsy experience for both physicians and patients. With Limaca's Precision™, physicians can expect superior volume and quality tissue acquisition, essential for precise histopathologic and molecular analysis.

The automated, motorized cutting mechanism allows for more tissue to be obtained in a single pass, saving critical procedure time and effort. Moreover, Precision™ offers precise control, excellent tissue quality, and a far shorter procedure compared to standard endoscopic biopsy devices. Limaca Medical is dedicated to addressing the need for improved biopsy diagnosis in pancreatic, liver, and lung cancers.

Their breakthrough device, Precision™, has the potential to enhance patient outcomes through more effective treatment or improved diagnosis of life-threatening conditions. This FDA breakthrough designation expedites the development and evaluation of their novel device. Limaca Medical's leadership, led by Carl Rickenbaugh and Assaf Klein, brings extensive experience in the medical device industry.

The company is also supported by partnerships with Trendlines Labs, Rambam Health Care, and HekaBio, enabling them to deliver innovative solutions globally. Stay updated with the latest news from Limaca Medical, as they continue to make advancements in precision medicine through improved biopsies